š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study is to compare the immune response, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-05
Trial ID
NCT00290303
Treatments Being Tested
To evaluate the persistence of antibodies against hepatitis B at 30, 42, 54...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-04-21
Trial ID
NCT00343915
Treatments Being Tested
Immunoprophylaxis with two hepatitis B vaccinations following the hepatitis...
Status
Unknown
Location
Beijing Youan Hospital, Capital Medical University
Start Date
2018-06-10
Trial ID
NCT03476083
Treatments Being Tested
The purpose of this study is to compare the immunogenicity and safety of th...
Status
Completed
Location
Hunan Provincial Center for Disease Control and Prevention
Start Date
2014-05
Trial ID
NCT02445703
Treatments Being Tested
This study will be conducted in two stages. In the diphtheria, tetanus, per...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06-16
Trial ID
NCT00228917
Treatments Being Tested
This study evaluates the immunogenicity and safety of Infanrix hexaā¢ (DTPa-...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-16
Trial ID
NCT01353703
Treatments Being Tested
Many short- and long-term consequences, including altered physiological par...
Status
Unknown
Location
Kirsehir Ahi Evran University
Start Date
2024-02-01
Trial ID
NCT06196502
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
This is a randomized, open-label, multicenter phase II study to evaluate th...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2025-06-08
Trial ID
NCT07069569
Treatments Being Tested
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested